Variant report

Variant	nsv521387
Chromosome Location	chr12:373120-388207
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:113)
CpG islands
(count:61)
Chromatin interactive
region (count:9)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:113 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr12:373538-373815	K562	blood:	n/a	n/a
2	BATF	chr12:382502-382775	GM12878	blood:	n/a	n/a
3	BCL3	chr12:377133-378098	A549	lung:	n/a	n/a
4	CEBPB	chr12:373496-373744	K562	blood:	n/a	n/a
5	CTCF	chr12:382320-382470	HCPEpiC	choroid plexus:	n/a	n/a
6	CTCF	chr12:376720-376870	SAEC	small airway:	n/a	n/a
7	CUX1	chr12:373538-373615	K562	blood:	n/a	n/a
8	EP300	chr12:373428-374103	K562	blood:	n/a	n/a
9	FOXA1	chr12:387844-388107	HepG2	liver:	n/a	n/a
10	FOXA1	chr12:382677-382977	T-47D	breast:	n/a	chr12:382894-382909 chr12:382860-382875
11	FOXA1	chr12:383279-383584	T-47D	breast:	n/a	chr12:383516-383528
12	FOXA1	chr12:382698-383077	T-47D	breast:	n/a	chr12:382894-382909 chr12:382860-382875
13	GATA1	chr12:373161-373880	K562	blood:	n/a	n/a
14	GATA1	chr12:373339-373784	PBDE	blood:	n/a	n/a
15	GATA2	chr12:373545-373749	SH-SY5Y	brain:	n/a	n/a
16	HNF4A	chr12:380373-380573	HepG2	liver:	n/a	chr12:380519-380534 chr12:380520-380534 chr12:380519-380534 chr12:380518-380536 chr12:380519-380534 chr12:380521-380533 chr12:380520-380533 chr12:380519-380534 chr12:380519-380534 chr12:380521-380533
17	IRF1	chr12:373834-373835	K562	blood:	n/a	n/a
18	JUND	chr12:373451-373805	K562	blood:	n/a	n/a
19	JUND	chr12:376215-376332	HepG2	liver:	n/a	n/a
20	MAFF	chr12:373589-373727	K562	blood:	n/a	n/a
21	MAFK	chr12:373506-373800	K562	blood:	n/a	n/a
22	MAFK	chr12:373576-373776	HepG2	liver:	n/a	n/a
23	MAFK	chr12:382695-382869	HepG2	liver:	n/a	n/a
24	MAX	chr12:373552-373712	K562	blood:	n/a	n/a
25	MAZ	chr12:373629-373715	K562	blood:	n/a	n/a
26	MYC	chr12:373496-373738	K562	blood:	n/a	n/a
27	POLR2A	chr12:379847-379946	HepG2	liver:	n/a	n/a
28	POLR2A	chr12:387781-388233	Hela-S3	cervix:	n/a	n/a
29	POLR2A	chr12:386735-386917	HepG2	liver:	n/a	n/a
30	POLR2A	chr12:376899-376979	MCF10A-Er-Src	breast:	n/a	n/a
31	POLR2A	chr12:383860-383946	Hela-S3	cervix:	n/a	n/a
32	POLR2A	chr12:388100-388148	H1-hESC	embryonic stem cell:	n/a	n/a
33	POLR2A	chr12:377019-377024	K562	blood:	n/a	n/a
34	POLR2A	chr12:377185-377548	H1-neurons	neurons:	n/a	n/a
35	POLR2A	chr12:375141-375583	HepG2	liver:	n/a	n/a
36	POLR2A	chr12:386924-387133	HepG2	liver:	n/a	n/a
37	POLR2A	chr12:387077-387624	GM12878	blood:	n/a	n/a
38	POLR2A	chr12:378709-379122	HUVEC	blood vessel:	n/a	n/a
39	POLR2A	chr12:379772-380539	K562	blood:	n/a	n/a
40	POLR2A	chr12:383831-383858	Hela-S3	cervix:	n/a	n/a
41	POLR2A	chr12:376257-377929	HepG2	liver:	n/a	n/a
42	POLR2A	chr12:378980-379214	SK-N-SH	brain:	n/a	n/a
43	POLR2A	chr12:384962-385168	Hela-S3	cervix:	n/a	n/a
44	POLR2A	chr12:377307-377352	GM12878	blood:	n/a	n/a
45	POLR2A	chr12:375235-375534	GM12878	blood:	n/a	n/a
46	POLR2A	chr12:376886-376887	GM12878	blood:	n/a	n/a
47	POLR2A	chr12:379937-380000	H1-hESC	embryonic stem cell:	n/a	n/a
48	POLR2A	chr12:376663-378544	A549	lung:	n/a	n/a
49	POLR2A	chr12:385463-386170	GM12878	blood:	n/a	n/a
50	POLR2A	chr12:386994-387404	GM12892	blood:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:378771-378821	AG09309	skin:	n/a
2	chr12:378771-378821	HCM	heart:	n/a
3	chr12:378771-378821	NHDF-neo	bronchial:	n/a
4	chr12:378771-378821	ProgFib	skin:	n/a
5	chr12:378771-378821	Hela-S3	cervix:	n/a
6	chr12:378771-378821	MCF10A-Er-Src	breast:	n/a
7	chr12:378771-378821	U87	brain:	n/a
8	chr12:378771-378821	A549	lung:	n/a
9	chr12:378771-378821	HEEpiC	esophagus:	n/a
10	chr12:378771-378821	HCPEpiC	choroid plexus:	n/a
11	chr12:378771-378821	AG10803	skin:	n/a
12	chr12:378771-378821	LNCaP	prostate:	n/a
13	chr12:378771-378821	HEK293	kidney:	embryo
14	chr12:378771-378821	HNPCEpiC	eye:	n/a
15	chr12:378771-378821	Jurkat	blood:	n/a
16	chr12:378771-378821	GM12878	blood:	n/a
17	chr12:378771-378821	NHBE	bronchial:	n/a
18	chr12:378771-378821	SAEC	small airway:	n/a
19	chr12:378771-378821	T-47D	breast:	n/a
20	chr12:378771-378821	GM12892	blood:	n/a
21	chr12:378771-378821	NH-A	brain:	n/a
22	chr12:378771-378821	HAEpiC	amniotic membrane:	n/a
23	chr12:378771-378821	ECC-1	luminal epithelium:	n/a
24	chr12:378771-378821	H1-hESC	embryonic stem cell:	embryo
25	chr12:378771-378821	SKMC	muscle:	n/a
26	chr12:378771-378821	GM19239	blood:	n/a
27	chr12:378771-378821	SK-N-SH	brain:	n/a
28	chr12:378771-378821	Hepatocyte	liver:	n/a
29	chr12:378771-378821	Caco-2	colon:	n/a
30	chr12:378771-378821	HRCEpiC	kidney:	n/a
31	chr12:378771-378821	ovcar-3	ovarian:	n/a
32	chr12:378771-378821	CMK	blood:	n/a
33	chr12:378771-378821	AG04450	lung:	fetal
34	chr12:378771-378821	AoSMC	blood vessel:	n/a
35	chr12:378771-378821	NB4	blood:	n/a
36	chr12:378771-378821	IMR90	lung:	fetal
37	chr12:378771-378821	PrEC	prostate:	n/a
38	chr12:378771-378821	AG09319	gingival:	n/a
39	chr12:378771-378821	HPAEpiC	pulmonary alveolar:	n/a
40	chr12:378771-378821	HepG2	liver:	n/a
41	chr12:378771-378821	HMEC	breast:	n/a
42	chr12:378771-378821	GM12891	blood:	n/a
43	chr12:378771-378821	HUVEC	blood vessel:	n/a
44	chr12:378771-378821	RPTEC	kidney:	n/a
45	chr12:378771-378821	GM06990	blood:	n/a
46	chr12:378771-378821	HIPEpiC	eye:	n/a
47	chr12:378771-378821	HL-60	blood:	n/a
48	chr12:378771-378821	AG04449	skin:	fetal
49	chr12:378771-378821	BE2_C	brain:	n/a
50	chr12:378771-378821	NT2-D1	testis:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:381899..385111-chr12:386819..388918,3	K562	blood:
2	chr12:371632..373367-chr12:383696..385601,2	MCF-7	breast:
3	chr12:381899..384416-chr12:386819..388918,2	K562	blood:
4	chr12:378409..380462-chr12:383368..386178,2	MCF-7	breast:
5	chr12:378409..380462-chr12:383368..386178,2	MCF-7	breast:
6	chr12:371815..374343-chr12:375834..377592,4	K562	blood:
7	chr12:381899..384416-chr12:386819..388918,2	K562	blood:
8	chr12:381899..385111-chr12:386819..388918,3	K562	blood:
9	chr12:371815..373339-chr12:375834..377443,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KDM5A-1	chr12:383120-386289	ENSG00000261799.1

No data

Variant related genes	Relation type
SLC6A13	TF binding region
ENSG00000261799	TF binding region
SLC6A13	CpG island
ENSG00000261799	CpG island
ENSG00000010379	chromatin interactions

Extended variants
information (count: 642 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:642 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs579526	chr12:373120-373121	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs562674454	chr12:373121-373122	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs578016164	chr12:373160-373161	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs368268362	chr12:373164-373165	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs140269303	chr12:373188-373189	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs554565123	chr12:373189-373190	Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs547386764	chr12:373209-373210	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs145329841	chr12:373210-373211	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs187378780	chr12:373215-373216	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs146431192	chr12:373265-373266	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs140796675	chr12:373272-373273	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs191828944	chr12:373291-373292	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs567506869	chr12:373327-373328	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs143838918	chr12:373354-373355	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs61906991	chr12:373424-373425	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs538351945	chr12:373441-373442	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs148155348	chr12:373452-373453	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs182564483	chr12:373498-373499	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs565501364	chr12:373533-373534	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs536146213	chr12:373543-373544	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs141945402	chr12:373550-373551	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs150237555	chr12:373577-373578	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs533677721	chr12:373578-373579	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs187073551	chr12:373587-373588	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs558604491	chr12:373606-373607	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs558467039	chr12:373623-373624	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs377167910	chr12:373631-373632	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs578076856	chr12:373653-373654	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs545131100	chr12:373679-373680	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs57996144	chr12:373709-373710	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs572322039	chr12:373770-373771	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs543358822	chr12:373853-373854	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs371804321	chr12:373855-373856	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs59100976	chr12:373875-373876	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs138821612	chr12:373880-373881	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs11062187	chr12:373881-373882	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs192783585	chr12:373900-373901	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs59844447	chr12:373921-373922	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs398076365	chr12:373933-373934	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs397806552	chr12:373934-373935	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs547133065	chr12:373968-373969	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs184310710	chr12:374032-374033	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs73604852	chr12:374036-374037	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs143148124	chr12:374104-374105	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs569658767	chr12:374125-374126	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs536936832	chr12:374165-374166	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs147478408	chr12:374175-374176	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs76085430	chr12:374232-374233	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs570506166	chr12:374291-374292	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs1972582	chr12:374302-374303	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance

Variant related diseases (count:83)

Disease	PMID	Source
Cancer	20164920	CNVD
Myelofibrosis	22110671	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Glaucoma	21310917	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Squamous cell cancer	19607727	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Mental retardation	17847001	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
abnormal development	18461090	CNVD
Ovarian cancer	20844748	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
small cell lung cancer	20016488	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Autism	22495309	CNVD
Ovarian cancer	21720365	CNVD
Myelodysplastic syndrome	21251322	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Cancer	20164919	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:303 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:371200-373200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr12:371400-373400	Enhancers	K562	blood
3	chr12:371600-373600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
4	chr12:371600-373600	Enhancers	HSMM	muscle
5	chr12:371800-373400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
6	chr12:371800-373400	Enhancers	NH-A	brain
7	chr12:371800-373600	Weak transcription	Primary T helper naive cells from peripheral blood	blood
8	chr12:371800-376800	Weak transcription	Brain Anterior Caudate	brain
9	chr12:372000-373400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
10	chr12:372000-376200	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
11	chr12:372000-376400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
12	chr12:372000-379200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
13	chr12:372200-373200	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
14	chr12:372200-373200	Enhancers	Muscle Satellite Cultured Cells	--
15	chr12:372400-377000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
16	chr12:372400-377200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
17	chr12:372400-377200	Weak transcription	HepG2	liver
18	chr12:372400-393600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
19	chr12:372800-373200	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr12:372800-373200	Enhancers	Left Ventricle	heart
21	chr12:372800-373200	ZNF genes & repeats	Lung	lung
22	chr12:372800-373200	Flanking Active TSS	HSMMtube	muscle
23	chr12:372800-373200	Bivalent Enhancer	NHDF-Ad	bronchial
24	chr12:372800-375000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
25	chr12:373000-373200	Enhancers	Placenta	Placenta
26	chr12:373000-373200	Enhancers	A549	lung
27	chr12:373000-373800	Enhancers	Thymus	Thymus
28	chr12:373000-374000	Enhancers	Fetal Heart	heart
29	chr12:373000-374200	Enhancers	Fetal Thymus	thymus
30	chr12:373200-373800	Enhancers	HSMMtube	muscle
31	chr12:373200-374400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
32	chr12:373200-377200	Weak transcription	Left Ventricle	heart
33	chr12:373200-378600	Weak transcription	Placenta	Placenta
34	chr12:373200-391200	Weak transcription	Lung	lung
35	chr12:373200-393600	Weak transcription	A549	lung
36	chr12:373200-401400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
37	chr12:373400-373600	Enhancers	iPS-18 Cell Line	embryonic stem cell
38	chr12:373400-374000	Weak transcription	K562	blood
39	chr12:373400-375400	Enhancers	Primary T cells from cord blood	blood
40	chr12:373400-377000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
41	chr12:373600-373800	Enhancers	Primary T helper naive cells from peripheral blood	blood
42	chr12:373600-387800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
43	chr12:373600-388200	Weak transcription	HSMM	muscle
44	chr12:373800-377200	Weak transcription	HSMMtube	muscle
45	chr12:373800-393000	Weak transcription	Thymus	Thymus
46	chr12:374000-374200	Enhancers	Primary T helper cells PMA-I stimulated	--
47	chr12:374000-374200	Enhancers	K562	blood
48	chr12:374200-389800	Weak transcription	Primary T helper cells PMA-I stimulated	--
49	chr12:375400-388000	Weak transcription	Primary T cells from cord blood	blood
50	chr12:376200-376800	Enhancers	Fetal Kidney	kidney

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links